[December 09, 2013]

Research and Markets: Global Victoza (Type 2 Diabetes) Report 2013 - Forecast and Market Analysis to 2022

Research and Markets (http://www.researchandmarkets.com/research/3svhff/victoza_type_2) has announced the addition of the "Global Victoza (Type 2 Diabetes) Report 2013 - Forecast and Market Analysis to 2022" report to their offering.

The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more than doubling over this period. The main drivers of growth will be the dramatic increase in disease prevalence and physicians' efforts to delay disease progression and reduce the costly burden of diabetic complications through the use of cmbination therapies and novel branded drugs.

Scope

• Overview of type 2 diabetes, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
• Detailed information on Victoza including product description, safety and efficacy profiles as well as a SWOT analysis.
• Sales forecast for Victoza for the top ten countries from 2012 to 2022.
• Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, India and China.
  

Reasons to buy

• Understand and capitalize by identifying products that are most likely to ensure a robust return
• Stay ahead of the competition by understanding the changing competitive landscape for type 2 diabetes
• Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
• Make more informed business decisions from insightful and in-depth analysis of Victoza performance
• Obtain sales forecast for Victoza from 2012-2022 in top ten countries (the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, India and China)

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Disease Overview

4 Disease Management

5 Competitive Assessment

6 Victoza (liraglutide)

7 Appendix

For more information visit http://www.researchandmarkets.com/research/3svhff/victoza_type_2

[ Back To TMCnet.com's Homepage ]